These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2874226)
21. Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. McMillen BA J Neural Transm; 1985; 64(1):1-12. PubMed ID: 2866230 [TBL] [Abstract][Full Text] [Related]
22. Alpha 2-adrenoceptor antagonist activity may account for the effects of buspirone in an anticonflict test in the rat. Gower AJ; Tricklebank MD Eur J Pharmacol; 1988 Oct; 155(1-2):129-37. PubMed ID: 2907485 [TBL] [Abstract][Full Text] [Related]
23. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential. Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents. Abou-Gharbia M; Moyer JA; Patel U; Webb M; Schiehser G; Andree T; Haskins JT J Med Chem; 1989 May; 32(5):1024-33. PubMed ID: 2565399 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide. Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533 [TBL] [Abstract][Full Text] [Related]
26. Presynaptic control of dopamine metabolism in the nucleus accumbens. Lack of effect of buspirone as demonstrated using in vivo voltammetry. Louilot A; Le Moal M; Simon H Life Sci; 1987 May; 40(20):2017-24. PubMed ID: 3573992 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities. Zagórska A; Partyka A; Bucki A; Kołaczkowski M; Jastrzębska-Więsek M; Czopek A; Siwek A; Głuch-Lutwin M; Bednarski M; Bajda M; Jończyk J; Piska K; Koczurkiewicz P; Wesołowska A; Pawłowski M Chem Biol Drug Des; 2019 Apr; 93(4):511-521. PubMed ID: 30422400 [TBL] [Abstract][Full Text] [Related]
28. Structure-intrinsic activity relationship studies in the group of 1-imido/amido substituted 4-(4-arylpiperazin-1-yl)cyclohexane derivatives; new, potent 5-HT1A receptor agents with anxiolytic- like activity. Bojarski AJ; Paluchowska MH; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E Bioorg Med Chem; 2006 Mar; 14(5):1391-402. PubMed ID: 16266808 [TBL] [Abstract][Full Text] [Related]
29. Use of animal models: toward anxioselective drugs. Eison MS Psychopathology; 1984; 17 Suppl 1():37-44. PubMed ID: 6143343 [TBL] [Abstract][Full Text] [Related]
30. Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system. Kolasa K; Fusi R; Garattini S; Consolo S; Ladinsky H J Pharm Pharmacol; 1982 May; 34(5):314-7. PubMed ID: 6123570 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens. Palacios G; Muro MA; Paz Marín A Brain Res; 1996 Dec; 742(1-2):141-8. PubMed ID: 9117387 [TBL] [Abstract][Full Text] [Related]
32. Anticonflict effects of acute and chronic treatments with buspirone and gepirone in rats. Yamashita S; Oishi R; Gomita Y Pharmacol Biochem Behav; 1995 Mar; 50(3):477-9. PubMed ID: 7617689 [TBL] [Abstract][Full Text] [Related]
33. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents. Norman MH; Rigdon GC; Navas F; Cooper BR J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539 [TBL] [Abstract][Full Text] [Related]
34. [The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives]. Abramets II; Obraztsova OG; Samoĭlovich IM; Kharin NA Eksp Klin Farmakol; 1992; 55(3):8-11. PubMed ID: 1360856 [TBL] [Abstract][Full Text] [Related]
35. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies. Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533 [TBL] [Abstract][Full Text] [Related]
36. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. Mansbach RS; Harrod C; Hoffmann SM; Nader MA; Lei Z; Witkin JM; Barrett JE J Pharmacol Exp Ther; 1988 Jul; 246(1):114-20. PubMed ID: 2455786 [TBL] [Abstract][Full Text] [Related]
37. Effects of buspirone and related compounds on suppressed operant responding in rats. Sanger DJ J Pharmacol Exp Ther; 1990 Aug; 254(2):420-6. PubMed ID: 1974634 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. VanderMaelen CP; Matheson GK; Wilderman RC; Patterson LA Eur J Pharmacol; 1986 Sep; 129(1-2):123-30. PubMed ID: 2876903 [TBL] [Abstract][Full Text] [Related]
39. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP). Bianchi G; Caccia S; Della Vedova F; Garattini S Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658 [TBL] [Abstract][Full Text] [Related]
40. [Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats]. Bogdanov MB; Gaĭnetdinov RR; Kudrin VS; Medvedev OS; Val'dman AV Biull Eksp Biol Med; 1991 May; 111(5):505-7. PubMed ID: 1715214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]